<VariationArchive VariationID="855137" VariationName="NM_000340.2(SLC2A2):c.156_181dup (p.Ile61fs)" VariationType="Duplication" Accession="VCV000855137" Version="18" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-29" DateCreated="2020-04-15" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="827709" VariationID="855137">
      <GeneList>
        <Gene Symbol="SLC2A2" FullName="solute carrier family 2 member 2" GeneID="6514" HGNC_ID="HGNC:11006" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3q26.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="170996347" stop="171026720" display_start="170996347" display_stop="171026720" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="170714136" stop="170744767" display_start="170714136" display_stop="170744767" Strand="-" />
          </Location>
          <OMIM>138160</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000340.2(SLC2A2):c.156_181dup (p.Ile61fs)</Name>
      <CanonicalSPDI>NC_000003.12:171014658:TAACATAGTTGTTGATAGCTTTTCGGT:TAACATAGTTGTTGATAGCTTTTCGGTAACATAGTTGTTGATAGCTTTTCGGT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>3q26.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="171014658" stop="171014659" display_start="171014658" display_stop="171014659" variantLength="26" positionVCF="171014658" referenceAlleleVCF="A" alternateAlleleVCF="ATAACATAGTTGTTGATAGCTTTTCGG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="170732447" stop="170732448" display_start="170732447" display_stop="170732448" variantLength="26" positionVCF="170732447" referenceAlleleVCF="A" alternateAlleleVCF="ATAACATAGTTGTTGATAGCTTTTCGG" />
      </Location>
      <ProteinChange>I61fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.170732449_170732474dup" Assembly="GRCh37">
            <Expression>NC_000003.11:g.170732449_170732474dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.171014660_171014685dup" Assembly="GRCh38">
            <Expression>NC_000003.12:g.171014660_171014685dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008108.1" sequenceAccession="NG_008108" sequenceVersion="1" change="g.17296_17321dup">
            <Expression>NG_008108.1:g.17296_17321dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000340.2" sequenceAccession="NM_000340" sequenceVersion="2" change="c.156_181dup" MANESelect="true">
            <Expression>NM_000340.2:c.156_181dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000331.1" sequenceAccession="NP_000331" sequenceVersion="1" change="p.Ile61fs">
            <Expression>NP_000331.1:p.Ile61fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001278659.2" sequenceAccession="NM_001278659" sequenceVersion="2" change="c.-239_-214dup">
            <Expression>NM_001278659.2:c.-239_-214dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001278658.2" sequenceAccession="NM_001278658" sequenceVersion="2" change="c.14+3847_14+3872dup">
            <Expression>NM_001278658.2:c.14+3847_14+3872dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1447936042" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000340.2(SLC2A2):c.156_181dup (p.Ile61fs) AND Fanconi-Bickel syndrome" Accession="RCV001060329" Version="9">
        <ClassifiedConditionList TraitSetID="5229">
          <ClassifiedCondition DB="MedGen" ID="C3495427">Fanconi-Bickel syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000340.2(SLC2A2):c.156_181dup (p.Ile61fs) AND multiple conditions" Accession="RCV002489662" Version="3">
        <ClassifiedConditionList TraitSetID="36493">
          <ClassifiedCondition DB="MedGen" ID="C3495427">Fanconi-Bickel syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0011860">Type 2 diabetes mellitus</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-01-27" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-25" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-04-15" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11810292</ID>
        </Citation>
        <DescriptionHistory Dated="2022-12-31">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="36493" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5064" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hepatorenal glycogenosis with renal Fanconi syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hepatic glycogenosis with amino aciduria and glucosuria</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Fanconi syndrome with intestinal malabsorption and galactose intolerance</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pseudo-Phlorizin diabetes</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogenosis Fanconi type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">HEPATIC GLYCOGENOSIS WITH FANCONI NEPHROPATHY</ElementValue>
                <XRef Type="MIM" ID="227810" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen storage disease due to GLUT2 deficiency</ElementValue>
                <XRef ID="MONDO:0009216" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Fanconi-Bickel syndrome</ElementValue>
                <XRef ID="Fanconi+Bickel+Syndrome/2784" DB="Genetic Alliance" />
                <XRef ID="61598006" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">FBS</ElementValue>
                <XRef Type="MIM" ID="227810" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2268" />
                <XRef ID="2268" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="2088" DB="Orphanet" />
              <XRef ID="C3495427" DB="MedGen" />
              <XRef ID="MONDO:0009216" DB="MONDO" />
              <XRef Type="MIM" ID="227810" DB="OMIM" />
            </Trait>
            <Trait ID="4949" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST</ElementValue>
                <XRef ID="125853" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Type II diabetes mellitus</ElementValue>
                <XRef ID="HP:0005978" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Type 2 diabetes mellitus</ElementValue>
                <XRef ID="Diabetes+mellitus+type+2/8215" DB="Genetic Alliance" />
                <XRef ID="HP:0005978" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0005148" DB="MONDO" />
                <XRef ID="44054006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Diabetes mellitus, noninsulin-dependent, late onset</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">T2D</ElementValue>
                <XRef Type="MIM" ID="125853" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">NIDDM</ElementValue>
                <XRef ID="HP:0005978" DB="Human Phenotype Ontology" />
                <XRef Type="MIM" ID="125853" DB="OMIM" />
              </Symbol>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301750</ID>
                <ID Source="BookShelf">NBK4144</ID>
              </Citation>
              <Citation Type="general" Abbrev="PLoS Currents, 2011">
                <URL>http://knol.google.com/k/raluca-mihaescu/genetic-risk-profiling-for-prediction/20113liwenx5c/9?collectionId=28qm4w0q65e4w.50#</URL>
              </Citation>
              <Citation Type="general" Abbrev="EGAPP, 2013">
                <ID Source="PubMed">23492873</ID>
              </Citation>
              <Citation Type="general" Abbrev="ES, 2012">
                <ID Source="PubMed">22962670</ID>
                <ID Source="pmc">3431581</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2023">
                <URL>https://www.nice.org.uk/guidance/cg181</URL>
                <CitationText>UK NICE Guidance, Clinical Guideline CG181, Cardiovascular disease: risk assessment and reduction, including lipid modification, 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2023">
                <URL>https://www.nice.org.uk/guidance/ng18</URL>
                <CitationText>UK NICE Guideline NG18, Diabetes (type 1 and type 2) in children and young people: diagnosis and management, 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2022">
                <URL>https://www.nice.org.uk/guidance/ng28</URL>
                <CitationText>UK NICE Guideline NG28, Type 2 diabetes in adults: management, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2023">
                <URL>https://www.nice.org.uk/guidance/ng136</URL>
                <CitationText>UK NICE Guideline NG136, Hypertension in adults: diagnosis and management, 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2020">
                <URL>https://www.nice.org.uk/guidance/ng3</URL>
                <CitationText>UK NICE Guideline NG3, Diabetes in pregnancy: management from preconception to the postnatal period</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2019">
                <URL>https://www.nice.org.uk/guidance/ng19</URL>
                <CitationText>UK NICE Guideline NG19, Diabetic foot problems: prevention and management, 2019</CitationText>
              </Citation>
              <XRef ID="C0011860" DB="MedGen" />
              <XRef ID="D003924" DB="MeSH" />
              <XRef ID="MONDO:0005148" DB="MONDO" />
              <XRef Type="MIM" ID="125853" DB="OMIM" />
              <XRef Type="primary" ID="HP:0005978" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0005965" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0100652" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5229" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5064" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hepatorenal glycogenosis with renal Fanconi syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hepatic glycogenosis with amino aciduria and glucosuria</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Fanconi syndrome with intestinal malabsorption and galactose intolerance</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pseudo-Phlorizin diabetes</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogenosis Fanconi type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">HEPATIC GLYCOGENOSIS WITH FANCONI NEPHROPATHY</ElementValue>
                <XRef Type="MIM" ID="227810" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen storage disease due to GLUT2 deficiency</ElementValue>
                <XRef ID="MONDO:0009216" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Fanconi-Bickel syndrome</ElementValue>
                <XRef ID="Fanconi+Bickel+Syndrome/2784" DB="Genetic Alliance" />
                <XRef ID="61598006" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">FBS</ElementValue>
                <XRef Type="MIM" ID="227810" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2268" />
                <XRef ID="2268" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="2088" DB="Orphanet" />
              <XRef ID="C3495427" DB="MedGen" />
              <XRef ID="MONDO:0009216" DB="MONDO" />
              <XRef Type="MIM" ID="227810" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2390507" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="8940513|MedGen:C3495427" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001225009" DateUpdated="2024-02-20" DateCreated="2020-04-15" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11810292</ID>
          </Citation>
          <Comment>Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 855137). This variant has not been reported in the literature in individuals affected with SLC2A2-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.002%). This sequence change creates a premature translational stop signal (p.Ile61Thrfs*23) in the SLC2A2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC2A2 are known to be pathogenic (PMID: 11810292).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC2A2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.170732447_170732448insTAACATAGTTGTTGATAGCTTTTCGG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3495427" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5450744" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_000340.2:c.156_181dup|OMIM:125853;227810" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002803855" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000340.2:c.156_181dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="125853" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="227810" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2390507" TraitType="Disease" MappingType="XRef" MappingValue="C3495427" MappingRef="MedGen">
        <MedGen CUI="C3495427" Name="Fanconi-Bickel syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5450744" TraitType="Disease" MappingType="XRef" MappingValue="227810" MappingRef="OMIM">
        <MedGen CUI="C3495427" Name="Fanconi-Bickel syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5450744" TraitType="Disease" MappingType="XRef" MappingValue="125853" MappingRef="OMIM">
        <MedGen CUI="C0011860" Name="Type 2 diabetes mellitus" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

